Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "67d800fcbb12917a333d56e2",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Flunarazine 5mg & Paracetamol 325mg",
"description": "METAPECT FLUNA is a clinically formulated combination of Flunarizine (5mg) and Paracetamol (325mg) designed to provide effective relief from migraines, headaches, and associated symptoms. This medication helps in reducing the frequency of migraine attacks while offering analgesic and antipyretic benefits. It is widely used for patients experiencing chronic migraines, vascular headaches, and fever-related pain.\n\n \nKey Benefits:\n \n\nEffective Migraine Prevention: Reduces the frequency and intensity of migraine attacks.\nPain Relief: Alleviates headaches, muscle pain, and fever-related discomfort.\nImproves Blood Circulation: Helps in regulating vascular function to prevent headaches.\nNon-Sedative Formula: Offers relief without excessive drowsiness when taken in the recommended dose.\nVersatile Use: Useful for managing tension headaches, migraines, and fever-induced pain.\n\n \nHow Does It Work?\n \n\nFlunarizine functions as a selective calcium channel blocker, reducing excessive nerve activity that triggers migraines and headaches. It prevents blood vessel constriction, thereby maintaining proper circulation in the brain. Paracetamol, on the other hand, acts by inhibiting pain signals and lowering fever by affecting the body’s temperature-regulating center in the brain. Together, they provide comprehensive relief from migraines and associated pain conditions.\n\n \nDirections for Use:\n \n\nTake METAPECT FLUNA as prescribed by your healthcare provider.\nSwallow the tablet whole with a glass of water.\nIt can be taken with or without food.\nDo not exceed the recommended dosage.\n \nSide Effects:\n \n\nWhile METAPECT FLUNA is generally well-tolerated, some individuals may experience:\n\nDrowsiness or Fatigue\nDizziness\nNausea or Stomach Discomfort\nDry Mouth\nMild Weight Gain (in long-term use of Flunarizine)\n\nIf you experience severe side effects like persistent dizziness, allergic reactions, or excessive drowsiness, seek medical attention immediately.",
"price": 55.0,
"discountamount": 17.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"migraines headaches",
"triggers migraines",
"experience drowsiness",
"generally welltolerated",
"metapect fluna",
"lowering fever",
"hand acts",
"brain paracetamol",
"excessive drowsiness",
"antipyretic benefits",
"offering analgesic",
"migraine attacks",
"medication helps",
"flunarizine 5mg",
"feverinduced pain",
"work flunarizine functions",
"paracetamol 325mg designed",
"pain conditions directions",
"inhibiting pain signals",
"fatigue dizziness nausea",
"healthcare provider swallow",
"provide comprehensive relief",
"bodys temperatureregulating center",
"maintaining proper circulation",
"recommended dose versatile",
"regulating vascular function",
"provide effective relief",
"clinically formulated combination"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2068,
"imageuri": "https://productimages.withfloats.com/actual/67d8012f1a1f4563d6e1675d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67d8012f1a1f4563d6e1675d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-17T11:01:16.948Z",
"updatedon": "2025-03-17T11:02:07.188Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/flunarazine-5mg-paracetamol-325mg/2068",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METAPECT FLUNA",
"category": "GENERAL RANGE",
"tags": [
"Flunarizine Domperidone Paracetamol tablets brand name",
"Flunarizine domperidone tablets Uses in Hindi",
"Paracetamol and Domperidone Uses",
"Flunarizine Paracetamol Domperidone",
"Flunarizine Domperidone ketorolac tromethamine in Hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67a35c945c5e728a14d08ad8",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin (25mg), Linagliptin (5mg)",
"description": "GLIEMPAFLOZIN LINA 25mg/5mg is a combination medication designed for individuals managing type 2 diabetes mellitus. It contains Empagliflozin (25mg) and Linagliptin (5mg), two potent anti-diabetic agents that work together to control blood sugar levels effectively. This medication is typically prescribed to patients who require dual therapy to achieve optimal glycemic control when diet and exercise alone are insufficient.\n\n \nKey Benefits :\n \n\nEffective Blood Sugar Control: Regulates blood glucose levels efficiently in patients with type 2 diabetes.\n\nWeight Management: Empagliflozin promotes weight loss by removing excess glucose from the body.\n\nHeart and Kidney Benefits: Shown to provide cardiovascular and renal protection, reducing the risk of heart failure.\n\nLower Risk of Hypoglycemia: Minimal chances of low blood sugar episodes compared to other anti-diabetic medications.\n\nConvenient Dual Therapy: Combines two complementary mechanisms for enhanced glycemic control in a single tablet.\n\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor): This component blocks Sodium-Glucose Cotransporter-2 (SGLT2) in the kidneys, preventing glucose reabsorption and facilitating its elimination through urine. This leads to a significant reduction in blood sugar levels.\n\nLinagliptin (DPP-4 Inhibitor): It inhibits Dipeptidyl Peptidase-4 (DPP-4) enzyme, which increases incretin hormone levels. This enhances insulin secretion and suppresses glucagon production, leading to better post-meal glucose control.\n\n \nDirections for Use\n \n\nTake one tablet daily, preferably at the same time each day.\n\nSwallow the tablet whole with water, with or without food.\n\nFollow the dosage regimen prescribed by your healthcare provider.\n\nRegular monitoring of blood sugar levels is recommended.\n\n \nSide Effects\n \n\nAlthough GLIEMPAFLOZIN LINA 25mg/5mg is generally well-tolerated, some patients may experience:\n\nFrequent Urination: Due to glucose excretion through urine.\n\nDehydration or Thirst: Increased urination may lead to mild dehydration.\n\nUrinary Tract Infections (UTIs): A common side effect associated with SGLT2 inhibitors.\n\nNasal Congestion or Sore Throat: Occasionally observed with DPP-4 inhibitors.\n\nGastrointestinal Discomfort: Mild nausea or diarrhea in some cases.\n\nHypotension (Low Blood Pressure): Especially in patients with pre-existing conditions.\n\n ",
"price": 345.0,
"discountamount": 104.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"urine dehydration",
"preexisting conditions",
"generally welltolerated",
"food follow",
"day swallow",
"significant reduction",
"single tablet",
"complementary mechanisms",
"provide cardiovascular",
"body heart",
"linagliptin 5mg",
"empagliflozin 25mg",
"glucose excretion",
"typically prescribed",
"tablet daily preferably",
"combination medication designed",
"dosage regimen prescribed",
"removing excess glucose",
"common side effect",
"thirst increased urination",
"gliempaflozin lina 25mg5mg",
"recommended side effects",
"blood sugar levels",
"enhances insulin secretion",
"enhanced glycemic control",
"hypoglycemia minimal chances",
"renal protection reducing",
"kidney benefits shown",
"require dual therapy",
"potent antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2048,
"imageuri": "https://productimages.withfloats.com/actual/67a35cb9b07d7c125c0f536d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35cb9b07d7c125c0f536d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:41:56.39Z",
"updatedon": "2025-03-17T11:04:56.55Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-linagliptin-5mg-/2048",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN LINA 25mg/ 5mg",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin-linagliptin 25-5 mg price",
"Empagliflozin and Linagliptin brands in India",
"empagliflozin-linagliptin 10-5 mg",
"Fixed dose combination of Empagliflozin and Linagliptin Tablets Price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c10e66641561b0446977f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VELAXFINE XR 37.5 ",
"description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/velaxfine-xr-37-5-134393",
"price": 58.0,
"discountamount": 17.4,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"MDD",
"SAD",
"day",
"GAD",
"food",
"life",
"SNRI",
"mood",
"75mg",
"need",
"EMAIL",
"water",
"brain",
"lives",
"225mg",
"37.5mg",
"levels",
"adults",
"option",
"control",
"ability",
"evening",
"morning",
"response",
"patients",
"Benefits",
"sweating",
"24 hours",
"adherence",
"intervals",
"increments",
"medication",
"depression",
"Venlafaxine",
"information",
"restlessness",
"palpitations",
"sterispharma",
"sterisonline",
"Introduction",
"Key Features",
"CALL/WHATSAPP",
"starting dose",
"panic disorder",
"Initial Dosage",
"patient safety",
"steady release",
"Anxiety Relief",
"excessive worry",
"dosage strength",
"Improved Quality",
"physical symptoms",
"treatment regimen",
"Regular monitoring",
"Dosage adjustments",
"Maintenance Dosage",
"therapeutic efficacy",
"Continued Monitoring",
"multiple daily doses",
"long-term management",
"Antidepressant Action",
"overall effectiveness",
"usual maintenance dose",
"potential side effects",
"social anxiety disorder",
"favorable safety profile",
"VELAXFINE XR 37.5 therapy",
"various anxiety disorders",
"consistent symptom relief",
"major depressive disorder",
"VELAXFINE XR 37.5 capsules",
"gastrointestinal discomfort",
"Administration Instructions",
"Extended-Release Formulation",
"generalized anxiety disorder",
"sustained therapeutic effects",
"serotonin-norepinephrine reuptake inhibitor"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1910,
"imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:44:06.065Z",
"updatedon": "2024-06-27T07:29:09.447Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/1910",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VELAXFINE XR 37.5 ",
"category": "NEUROLOGY RANGE",
"tags": [
"venlafaxine 37.5 mg",
"VELAXFINE XR 37.5",
"",
"VELAXFINE XR 37.5 side effects",
"venlafaxine 37.5mg used for",
"venlafaxine urinary side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c09b805b00e1ad41ca790",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TP MATE 50 ",
"description": "TP MATE 50 \nTopiramate (50mg)\nIntroduction:\n\nTP MATE 50 contains Topiramate, a versatile anticonvulsant and migraine prophylactic medication. With a dosage strength of 50mg, TP MATE 50 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 50 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 50 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 50 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 50 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 50 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 50-100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 50 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 50 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-50-133634",
"price": 99.0,
"discountamount": 29.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"life",
"food",
"50mg",
"25mg",
"risk",
"EMAIL",
"night",
"option",
"adults",
"anxiety",
"quality",
"symptoms",
"severity",
"50-100mg",
"low dose",
"epilepsy",
"patients",
"Benefits",
"200-400mg",
"two doses",
"condition",
"migraines",
"Topiramate",
"depression",
"mood swings",
"weight gain",
"weight loss",
"information",
"Key Features",
"sterispharma",
"Introduction",
"initial dose",
"sterisonline",
"CALL/WHATSAPP",
"added benefit",
"various types",
"mood disorders",
"patient safety",
"Initial Dosage",
"effective dose",
"sodium channels",
"dosage strength",
"migraine attacks",
"bipolar disorder",
"weight reduction",
"neuronal activity",
"seizure frequency",
"daily functioning",
"other medications",
"Weight Management",
"Regular monitoring",
"Mood Stabilization",
"TP MATE 50 therapy",
"glutamate activity",
"TP MATE 50 tablets",
"migraine prevention",
"long-term management",
"Migraine Prophylaxis",
"Continued Monitoring",
"common starting dose",
"many anticonvulsants",
"therapeutic efficacy",
"Anticonvulsant Action",
"usual maintenance dose",
"potential side effects",
"partial-onset seizures",
"GABAergic transmission",
"Lennox-Gastaut syndrome",
"favorable safety profile",
"versatile anticonvulsant",
"neurotransmitter activity",
"stable therapeutic levels",
"Administration Instructions",
"mood-stabilizing properties",
"consistent dosing schedules",
"migraine prophylactic medication",
"generalized tonic-clonic seizures"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1905,
"imageuri": "https://productimages.withfloats.com/actual/666c09bbf068be46bdec8995.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c09bbf068be46bdec8995.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:13:28.046Z",
"updatedon": "2024-06-26T06:01:34.175Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-50-/1905",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TP MATE 50 ",
"category": "NEUROLOGY RANGE",
"tags": [
"TP MATE 50",
"",
"Topiramate (50mg)",
"topiramate uses",
"topiramate 50 mg",
"topiramate side effects",
"topiramate side effects weight loss"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666c08e7c91739182c9574b6",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TP MATE 100 ",
"description": "TP MATE 100 \nTopiramate (100mg)\nIntroduction:\n\nTP MATE 100 contains Topiramate, a broad-spectrum anticonvulsant and migraine prophylactic medication. With a dosage strength of 100mg, TP MATE 100 is designed to manage seizures in epilepsy and prevent migraines, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nTP MATE 100 is highly effective in treating various types of seizures, including partial-onset seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. It stabilizes neuronal activity by enhancing GABAergic transmission, blocking sodium channels, and inhibiting glutamate activity.\nMigraine Prophylaxis:\n\nTopiramate is widely used for preventing migraines. By modulating neurotransmitter activity, TP MATE 100 reduces the frequency and severity of migraine attacks, helping patients manage their condition and improve their daily functioning.\nWeight Management:\n\nAn added benefit of TP MATE 100 is its potential to assist with weight loss. Unlike many anticonvulsants, Topiramate may lead to weight reduction, which can be beneficial for patients concerned about weight gain associated with other medications.\nMood Stabilization:\n\nTopiramate has mood-stabilizing properties, making it useful for patients with coexisting mood disorders such as bipolar disorder. It helps in stabilizing mood swings and reducing symptoms of anxiety and depression.\nWell-Tolerated and Safe:\n\nTP MATE 100 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and migraines.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of TP MATE 100 for adults with epilepsy typically starts at a low dose, gradually increasing to reduce the risk of side effects. A common starting dose is 25-50mg per day, increasing weekly by 25-50mg until the effective dose is reached. The usual maintenance dose ranges from 200-400mg per day, divided into two doses.\nInitial Dosage for Migraine Prophylaxis:\n\nFor migraine prevention, the initial dose is 25mg taken once daily, usually at night. The dose may be increased weekly by 25mg, up to a recommended dose of 100mg per day, divided into two doses.\nAdministration Instructions:\n\nTP MATE 100 tablets should be taken orally with or without food. It is important to maintain consistent dosing schedules to ensure stable therapeutic levels.\nContinued Monitoring:\n\nRegular monitoring of seizure frequency, migraine attacks, and potential side effects is essential during TP MATE 100 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tp-mate-100-133633",
"price": 149.0,
"discountamount": 44.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"life",
"food",
"25mg",
"risk",
"50mg",
"EMAIL",
"night",
"100mg",
"option",
"adults",
"anxiety",
"quality",
"symptoms",
"severity",
"low dose",
"epilepsy",
"patients",
"Benefits",
"200-400mg",
"two doses",
"condition",
"migraines",
"Topiramate",
"depression",
"mood swings",
"weight gain",
"weight loss",
"information",
"Key Features",
"sterispharma",
"Introduction",
"initial dose",
"sterisonline",
"CALL/WHATSAPP",
"added benefit",
"various types",
"mood disorders",
"patient safety",
"Initial Dosage",
"effective dose",
"sodium channels",
"dosage strength",
"migraine attacks",
"bipolar disorder",
"weight reduction",
"neuronal activity",
"seizure frequency",
"daily functioning",
"other medications",
"Weight Management",
"Regular monitoring",
"Mood Stabilization",
"glutamate activity",
"migraine prevention",
"TP MATE 100 therapy",
"TP MATE 100 tablets",
"long-term management",
"Migraine Prophylaxis",
"Continued Monitoring",
"common starting dose",
"many anticonvulsants",
"therapeutic efficacy",
"Anticonvulsant Action",
"usual maintenance dose",
"potential side effects",
"partial-onset seizures",
"GABAergic transmission",
"Lennox-Gastaut syndrome",
"favorable safety profile",
"neurotransmitter activity",
"stable therapeutic levels",
"Administration Instructions",
"mood-stabilizing properties",
"consistent dosing schedules",
"broad-spectrum anticonvulsant",
"migraine prophylactic medication",
"generalized tonic-clonic seizures"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1904,
"imageuri": "https://productimages.withfloats.com/actual/666c08eb0b4fc76a99a41986.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666c08eb0b4fc76a99a41986.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T09:09:59.43Z",
"updatedon": "2024-06-26T06:09:24.07Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/tp-mate-100-/1904",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TP MATE 100 ",
"category": "NEUROLOGY RANGE",
"tags": [
"tp mate 100 tablet price",
"topiramate side effects weight loss",
"topiramate side effects",
"tp mate 100 tablet in hindi language"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666be6b8aa93342004eef58f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ROPINPRIME 2 ",
"description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629",
"price": 135.0,
"discountamount": 40.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"RLS",
"1mg",
"8mg",
"life",
"aids",
"food",
"brain",
"Order",
"EMAIL",
"0.5mg",
"water",
"0.25mg",
"action",
"nausea",
"bedtime",
"disease",
"tremors",
"patients",
"Benefits",
"condition",
"Parkinson",
"stiffness",
"Ropinirole",
"likelihood",
"medication",
"information",
"Introduction",
"bradykinesia",
"independence",
"tolerability",
"initial dose",
"sterisonline",
"sterispharma",
"greater ease",
"Key Features",
"CALL/WHATSAPP",
"sleep quality",
"starting dose",
"motor symptoms",
"patient safety",
"multiple doses",
"Initial Dosage",
"overall comfort",
"treatment plans",
"slowed movement",
"symptom control",
"patient response",
"symptom severity",
"daily activities",
"clinical response",
"Maintenance doses",
"Regular monitoring",
"dopamine receptors",
"uncontrollable urge",
"2mg dosage strength",
"Ropinprime 2 therapy",
"healthcare providers",
"therapeutic efficacy",
"Continued Monitoring",
"dopaminergic activity",
"overall motor function",
"potential side effects",
"potent dopamine agonist",
"Improved Motor Function",
"uncomfortable sensations",
"flexible dosing regimens",
"individual patient needs",
"Administration Instructions",
"Swallow Ropinprime 2 tablets",
"Restless Legs Syndrome Relief"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1895,
"imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T06:44:08.261Z",
"updatedon": "2024-06-27T07:33:46.566Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ROPINPRIME 2 ",
"category": "NEUROLOGY RANGE",
"tags": [
"Ropinirole (2mg)",
"ROPINPRIME 2",
"ropinirole side effects",
"ropinirole side effects: weight gain",
"ropinirole side effects in elderly"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666be5a070774b1f84f699ad",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ROPINPRIME 1 ",
"description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628",
"price": 124.0,
"discountamount": 37.2,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"RLS",
"day",
"8mg",
"life",
"food",
"EMAIL",
"water",
"0.5mg",
"Order",
"brain",
"nausea",
"action",
"0.25mg",
"bedtime",
"disease",
"tremors",
"patients",
"Benefits",
"movement",
"mechanism",
"condition",
"Parkinson",
"stiffness",
"medication",
"likelihood",
"Ropinirole",
"flexibility",
"information",
"bradykinesia",
"independence",
"tolerability",
"Introduction",
"sterisonline",
"initial dose",
"sterispharma",
"Key Features",
"greater ease",
"CALL/WHATSAPP",
"starting dose",
"sleep quality",
"motor symptoms",
"Initial Dosage",
"multiple doses",
"patient safety",
"symptom control",
"treatment plans",
"dosing regimens",
"Flexible Dosing",
"overall comfort",
"symptom severity",
"patient response",
"daily activities",
"Maintenance doses",
"clinical response",
"dopamine receptors",
"Regular monitoring",
"1mg dosage strength",
"uncontrollable urge",
"Continued Monitoring",
"therapeutic efficacy",
"healthcare providers",
"Ropinprime 1 therapy",
"dopaminergic activity",
"overall motor function",
"potential side effects",
"potent dopamine agonist",
"Improved Motor Function",
"individual patient needs",
"uncomfortable sensations",
"Administration Instructions",
"Swallow Ropinprime 1 tablets",
"Restless Legs Syndrome Relief"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1894,
"imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T06:39:28.983Z",
"updatedon": "2024-06-26T07:04:00.123Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ROPINPRIME 1 ",
"category": "NEUROLOGY RANGE",
"tags": [
"ROPINPRIME 1",
"ropinirole side effects in elderly",
"ropinirole side effects",
"ropinirole warnings"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666be4714cb45413344ec323",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ROPINPRIME 0.5 ",
"description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627",
"price": 60.0,
"discountamount": 18.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"RLS",
"aids",
"life",
"food",
"Order",
"water",
"brain",
"EMAIL",
"0.25mg",
"nausea",
"action",
"bedtime",
"disease",
"tremors",
"patients",
"Benefits",
"stiffness",
"condition",
"Parkinson",
"Ropinirole",
"likelihood",
"medication",
"information",
"Introduction",
"initial dose",
"independence",
"greater ease",
"tolerability",
"Key Features",
"sterispharma",
"bradykinesia",
"sterisonline",
"CALL/WHATSAPP",
"sleep quality",
"starting dose",
"patient safety",
"motor symptoms",
"Initial Dosage",
"overall comfort",
"treatment plans",
"slowed movement",
"symptom control",
"dopamine agonist",
"patient response",
"daily activities",
"symptom severity",
"clinical response",
"Regular monitoring",
"dopamine receptors",
"uncontrollable urge",
"Continued Monitoring",
"healthcare providers",
"therapeutic efficacy",
"0.5mg dosage strength",
"dopaminergic activity",
"Ropinprime 0.5 therapy",
"overall motor function",
"potential side effects",
"Improved Motor Function",
"individual patient needs",
"uncomfortable sensations",
"flexible dosing regimens",
"Administration Instructions",
"Restless Legs Syndrome Relief",
"Swallow Ropinprime 0.5 tablets"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1893,
"imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-14T06:34:25.708Z",
"updatedon": "2024-06-26T07:04:57.853Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ROPINPRIME 0.5 ",
"category": "NEUROLOGY RANGE",
"tags": [
"ropinprime 0.5 mg tablet 10",
"ropinprime 0.5 mg tablet uses",
"ropin 0.5 injection",
"ropinirole warnings",
"ropinirole side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666ae2d4ca84cd189c25cb49",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "QT-PINE 25",
"description": "QT-PINE 25 \nQuetiapine (25mg)\nIntroduction:\n\nQT-PINE 25 contains Quetiapine, an atypical antipsychotic medication renowned for its efficacy in managing various psychiatric conditions. With a dosage strength of 25mg, QT-PINE 25 is designed to address specific mental health needs with precision and effectiveness.\nKey Features and Benefits:\n\nAntipsychotic Properties:\n\nQuetiapine in QT-PINE 25 acts on dopamine and serotonin receptors in the brain, alleviating symptoms of schizophrenia such as hallucinations, delusions, and thought disorders.\nMood Stabilization:\n\nQT-PINE 25 is beneficial in stabilizing mood swings associated with bipolar disorder, preventing episodes of mania and depression. It helps maintain emotional balance and improves overall well-being.\nAntidepressant Effects:\n\nIn addition to its antipsychotic properties, Quetiapine in QT-PINE 25 exhibits antidepressant effects by modulating serotonin and norepinephrine levels. This makes it a valuable option for individuals with major depressive disorder (MDD).\nAnxiolytic Action:\n\nQT-PINE 25's anxiolytic properties contribute to reducing anxiety symptoms in conditions such as generalized anxiety disorder (GAD) and social anxiety disorder (SAD), promoting a calmer mental state.\nDosage and Administration:\n\nStarting Dosage and Titration:\nThe initial recommended dose of QT-PINE 25 is 25mg taken orally once daily. Dosage adjustments may be made by your healthcare provider based on response and tolerability.\nAdministration Guidelines:\nSwallow QT-PINE 25 tablets whole with water, without crushing or chewing them. Take it consistently at the same time each day for optimal results.\nDuration of Use:\nContinue using QT-PINE 25 as directed by your doctor, even if symptoms improve. Abrupt discontinuation can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/qt-pine-25-133617",
"price": 44.5,
"discountamount": 13.35,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"MDD",
"SAD",
"Use",
"GAD",
"25mg",
"EMAIL",
"brain",
"mania",
"water",
"doctor",
"relapse",
"Duration",
"Benefits",
"efficacy",
"episodes",
"addition",
"response",
"dopamine",
"precision",
"same time",
"delusions",
"Titration",
"depression",
"Quetiapine",
"individuals",
"information",
"mood swings",
"sterisonline",
"sterispharma",
"Key Features",
"tolerability",
"Introduction",
"schizophrenia",
"effectiveness",
"CALL/WHATSAPP",
"hallucinations",
"QT-PINE 25 acts",
"Starting Dosage",
"dosage strength",
"optimal results",
"valuable option",
"anxiety symptoms",
"bipolar disorder",
"thought disorders",
"emotional balance",
"Anxiolytic Action",
"QT-PINE 25 tablets",
"Mood Stabilization",
"Dosage adjustments",
"overall well-being",
"serotonin receptors",
"healthcare provider",
"withdrawal symptoms",
"calmer mental state",
"anxiolytic properties",
"norepinephrine levels",
"Abrupt discontinuation",
"Antidepressant Effects",
"social anxiety disorder",
"Antipsychotic Properties",
"initial recommended dose",
"major depressive disorder",
"Administration Guidelines",
"generalized anxiety disorder",
"specific mental health needs",
"various psychiatric conditions",
"atypical antipsychotic medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1885,
"imageuri": "https://productimages.withfloats.com/actual/666ae344475de163fe90f46c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666ae344475de163fe90f46c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-13T12:15:16.921Z",
"updatedon": "2024-06-26T07:36:04.861Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/qt-pine-25/1885",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "QT-PINE 25 ",
"category": "NEUROLOGY RANGE",
"tags": [
"quetiapine for sleep side effects",
"qutipin 25 uses in hindi",
"qutipin 25 uses in english",
"quetiapine for sleep dosage"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}